Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups. (Q45038438)
Jump to navigation
Jump to search
scientific article published in August 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups. |
scientific article published in August 2004 |
Statements
Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups (English)
Petra Muus
Stefan Suciu
Sergio Amadori
Roel Willemze
Franco Mandelli
Dominique Selleslag
Anthony Ho
Claudio Denzlinger
Giuseppe Leone
Piero Fabris
Marco Vignetti
Anne Hagemeijer
Filip Beeldens
Ozlem Anak
Theo De Witte
EORTC leukemia group
GIMEMA leukemia group